Genentech Inc.

Industry / private company


Location: San Francisco, CA, United States (USA) (US) US

ISNI: 0000000405344718

ROR: https://ror.org/011qkaj49

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition) () Cossarizza A, Acs A, Adam D, Adam-Klages S, Agace WW, Aghaeepour N, Akdis M, et al. Journal article The IL-22-oncostatin M axis promotes intestinal inflammation and tumorigenesis (2025) Cineus R, Luo Y, Saliutina M, Manna S, Cancino CA, Velasco Blázquez L, Wang L, et al. Journal article Image-based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno-oncology Biomarker Working Group on Breast Cancer (2024) Jahangir CA, Page DB, Broeckx G, Gonzalez CA, Burke C, Murphy C, Reis-Filho JS, et al. Journal article, Review article Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 study (2023) Hurvitz SA, Bardia A, Quiroga V, Park YH, Blancas I, Alonso-Romero JL, Vasiliev A, et al. Journal article Spatial analyses of immune cell infiltration in cancer: current methods and future directions. A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer (2023) Page DB, Broeckx G, Jahangir CA, Verbandt S, Gupta RR, Thagaard J, Khiroya R, et al. Journal article, Review article Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: a report of the international immuno-oncology biomarker working group (2023) Thagaard J, Broeckx G, Page DB, Jahangir CA, Verbandt S, Kos Z, Gupta R, et al. Journal article, Review article Biomarker Data from the Phase III KATHERINE Study of Adjuvant T-DM1 versus Trastuzumab for Residual Invasive Disease after Neoadjuvant Therapy for HER2-Positive Breast Cancer (2023) Denkert C, Lambertini C, Fasching P, Pogue-Geile KL, Mano MS, Untch M, Wolmark N, et al. Journal article Towards Giving Timely Formative Feedback and Hints to Novice Programmers (2022) Jeuring J, Keuning H, Marwan S, Bouvier D, Izu C, Kiesler N, Lehtinen T, et al. Conference contribution Association of bronchial steroid inducible methylation quantitative trait loci with asthma and chronic obstructive pulmonary disease treatment response (2022) Slob EMA, Faiz A, Van Nijnatten J, Vijverberg SJH, Longo C, Kutlu M, Chew FT, et al. Journal article Determinants of expression of SARS-CoV-2 entry-related genes in upper and lower airways (2022) Aliee H, Massip F, Qi C, Stella De Biase M, Van Nijnatten J, Kersten ETG, Kermani NZ, et al. Journal article